Ionis and Royalty Pharma enter into royalty agreement for up to $1.1 billion to further advance Ionis’ genetic medicines and commercial readiness Yahoo Finance Nawigacja wpisu Penn Medicine’s New ASPIRE Program Seeks to Boost Nursing’s … – HealthLeaders Media Hong Kong customs seizes HK$600,000 worth of Covid medicine ‘intended’ for mainland China – South China Morning Post
